Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Pharmaceutical Analytical Testing Outsourcing Market
5.1. COVID-19 Landscape: U.S. Pharmaceutical Analytical Testing Outsourcing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global U.S. Pharmaceutical Analytical Testing Outsourcing Market, By Services
8.1. U.S. Pharmaceutical Analytical Testing Outsourcing Market, by Services, 2022-2030
8.1.1. Bioanalytical Testing
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Method Development and Validation
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Stability Testing
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Other Testing Services
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global U.S. Pharmaceutical Analytical Testing Outsourcing Market, By End-use
9.1. U.S. Pharmaceutical Analytical Testing Outsourcing Market, by End-use, 2022-2030
9.1.1. Pharmaceutical Companies
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Biopharmaceutical Companies
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Contract Research Organizations
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global U.S. Pharmaceutical Analytical Testing Outsourcing Market, Regional Estimates and Trend Forecast
10.1. U.S.
10.1.1. Market Revenue and Forecast, by Services (2017-2030)
10.1.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 11. Company Profiles
11.1. West Pharmaceutical Services, Inc.
11.1.1. Company Overview
11.1.2. Services Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. SGS SA
11.2.1. Company Overview
11.2.2. Services Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Eurofins Scientific
11.3.1. Company Overview
11.3.2. Services Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Pace Analytical Services Llc
11.4.1. Company Overview
11.4.2. Services Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Intertek Group Plc
11.5.1. Company Overview
11.5.2. Services Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Pharmaceutical Product Development, LLC.
11.6.1. Company Overview
11.6.2. Services Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Wuxi AppTec, Inc.
11.7.1. Company Overview
11.7.2. Services Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Boston Analytical
11.8.1. Company Overview
11.8.2. Services Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Charles River Laboratories
11.9.1. Company Overview
11.9.2. Services Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms